Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Accumulated Expenses (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Other Accumulated Expenses for 7 consecutive years, with $106000.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 83.69% to $106000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $106000.0 through Dec 2025, down 83.69% year-over-year, with the annual reading at $106000.0 for FY2025, 83.69% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $106000.0 at Whitehawk Therapeutics, up from $105000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.5 million in Q3 2021, with the low at $10805.0 in Q2 2021.
  • Average Other Accumulated Expenses over 4 years is $412493.1, with a median of $114000.0 recorded in 2025.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 6976.32% in 2021, then tumbled 83.69% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $496000.0 in 2021, then surged by 34.68% to $668000.0 in 2022, then decreased by 2.69% to $650000.0 in 2024, then crashed by 83.69% to $106000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $106000.0, $105000.0, and $114000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.